Header Logo

Connection

JOHN LYDON to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications JOHN LYDON has written about Drug Evaluation, Preclinical.
JOHN LYDON
Connection Strength
0.028
Drug Evaluation, Preclinical
  1. Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulation. J Clin Invest. 2015 Apr; 125(4):1726-38.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.